Results 251 to 260 of about 24,885 (307)

A Pharmacologic Model Predicts that Tumor Debulking Improves CAR T-cell Efficacy in Large B-cell Lymphoma. [PDF]

Blood Cancer Discov
Pomeroy AE, Sworder BJ, Plana D, Cao Y, Alizadeh AA, Palmer AC.   +5 more
europepmc   +1 more source

The Technology Valley of Death of Circular Economy Solutions: A System Dynamics Simulation of Business Strategies for the Second‐Use Battery Industry

Business Strategy and the Environment, EarlyView.
ABSTRACT Retired electric vehicle (EV) batteries can be repurposed to stationary storage batteries. While this circularity solution has attracted attention from entrepreneurs, falling battery prices, along with the longer lifetime of new batteries, high consumer expectations and limited governmental support challenge the approach.
Juliane Seika, Merla Kubli
wiley   +1 more source

Idecabtagene vicleucel manufacturing and clinical value of out-of-specification products in relapsed and refractory MM. [PDF]

Blood Adv
Sidana S, Lin Y, Cowan AJ, Rodríguez-Otero P, Scheid C, Mueller PJ, Broussard C, Krengel P, Li Y, Piault R, Corrao A, Ho C, Patel K.   +12 more
europepmc   +1 more source

Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3.

Blood
van Meerten T, Kersten MJ, Iacoboni G, Hess G, Mutsaers P, García-Sancho AM, Goy A, Giné E, Hill BT, Weng WK, Reagan PM, Patel K, Galal A, Herbaux C, Sanderson R, Forcade E, Topp MS, Houot R, Zheng D, Zhang W, Kanska J, Shen RR, Damico Khalid R, Kloos I, Dreyling M, Wang ML.   +25 more
europepmc   +1 more source

Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma. [PDF]

J Clin Oncol
Neelapu SS, Chavez JC, Sehgal AR, Epperla N, Ulrickson ML, Bachy E, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA, Oluwole OO, Yakoub-Agha I, Khanal R, Rosenblatt JD, Wulff J, Shen RR, Zhang W, Poddar S, Miao H, Nikolajeva O, Jacobson CA.   +22 more
europepmc   +1 more source

Five-Year Analysis of the JULIET Trial of Tisagenlecleucel in Patients With Relapsed/Refractory Large B-Cell Lymphoma. [PDF]

J Clin Oncol
Maziarz RT, Bishop MR, Tam CS, Borchmann P, Worel N, McGuirk JP, Holte H, Waller EK, Jaglowski S, Andreadis C, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Janakiram M, Hsu J, Izutsu K, Kersten MJ, Ghosh M, Wagner-Johnston N, Kato K, Corradini P, Ma W, Han X, Nuortti M, Awasthi R, Mundt KE, Majdan M, Maier HJ, Jegerlehner A, Salles G, Schuster SJ.   +33 more
europepmc   +1 more source

Prevalence, correlates, and patterns of leaving firearms unattended in vehicles among US firearm owners. [PDF]

Inj Epidemiol
Testa A, Thompson J, Carriker C, Jackson D, Semenza D, Tsai J.   +5 more
europepmc   +1 more source

Measuring the accessibility of veterinary care for companion animals in England and Wales. [PDF]

Anim Welf
Clark S, Clarke G, James W, Lomax N.
europepmc   +1 more source

Road safety threats and occupational health risk associated with psychoactive substance use and dependence risk among commercial drivers: WHO ASSIST evidence from Ghana. [PDF]

BMC Public Health
Bebangnidong J, Norvivor FA, Umar A, Bautsi DA, Gmayinaam VU.   +4 more
europepmc   +1 more source

A comparison of car ownership models

, 2004
de Jong, G., Fox, J., Pieters, M., Daly, A.J., Smit, R.   +4 more
openaire   +1 more source